Regulatory News Service (RNS)

View all

Results, Reports and Presentations

• June 2025 Investor Presentation

  June 2 2025 Download (2.27MB)

• Indivior Q1 2025 Financial Results

  April 24 2025 Download (153KB)

• Annual Report and Accounts 2024

  March 17 2025 Download (7.25MB)

• Indivior FY and Q4 2024 Financial Results

  February 20 2025 Download (589KB)

• Indivior Announces Q3 2024 Financial Results

  October 24 2024 Download (334KB)

View all

Latest News

• Indivior Announces Completion of Cancellation of Secondary Listing on London Stock Exchange; Primary Listing on Nasdaq to be Maintained

  July 25 2025

• Indivior Real World Evidence Study Finds Medications for Opioid Use Disorder, Particularly Extended-Release Buprenorphine, Reduced Odds of Emergency Department Visits for Patients with Opioid Use Disorder

  July 23 2025

• Indivior Appoints Vanessa Procter as Executive Vice President of Corporate Affairs

  July 8 2025

• Indivior Announces Inclusion in the U.S. Russell 2000® and 3000® Indexes

  June 30 2025

• Indivior Appoints Tony Kingsley to the Board of Directors

  June 24 2025

View all